Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Obituaries

Obituary: Frank R. Busch

by Linda Wang
July 20, 2018 | A version of this story appeared in Volume 96, Issue 30

 

“Frank conducted research under Herman Richey at Pennsylvania State University and Glenn Berchtold at Massachusetts Institute of Technology. A process development chemist at Lilly and Pfizer for 34 years, Frank developed Chantix, Geodon, and other pharmaceuticals. His team at Pfizer received the ACS Heroes of Chemistry Award in 2015 for their development of Xeljanz. He retired in 2016. The following are some quotes from his friends and colleagues: ‘His work blended creativity with unwavering dependability.’ ‘Careful and thorough documentation; instrumental in gaining regulatory approval for CMC sections.’ ‘Calm and knowledgeable approach, never letting suggestions go without careful consideration.’ ‘Amazingly valuable contributor to projects—intelligent, collaborative, and kind; role model of scientific excellence, genuine contributor to humanity.’ Frank was married for 40 years. He was dedicated to Scouting and his church.”—Edward K. Watkins, friend and colleague

Most recent title: Research fellow, Pfizer

Education: B.S., chemistry, Pennsylvania State University, 1978; Ph.D., organic chemistry, Massachusetts Institute of Technology, 1982

Survivors: Wife, Constance; daughter, Dorothy; sons, Robert and Paul; grandchildren

To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.